Somos S, Schneider I, Raskó I
Department of Dermatology, Pecs University Medical School, Hungary.
Anticancer Res. 1997 Jan-Feb;17(1B):753-6.
We describe herein a 29-year-old patient who was recognized as having a xeroderma pigmentosum variant or pigmented xerodermoid in the early adult life since sunlight sensitivity caused degenerative changes in the skin and cutaneous carcinomas. The patient had 11 skin tumours removed over an interval of two years, of which four proved to be squamous cell carcinoma, one basal cell carcinoma and six precancerous conditions. Then the patient was treated with isotretinoin at a dosage of 2 mg per kilogram of body weight per day for two years. During two years of treatment with isotretinoin a further three tumours were removed givind a histological result of basal cell carcinoma and Bowen's diseases. The patient tolerated well this low dosage retinoid treatment. Only 50 or so of these patients are described in the world literature.
我们在此描述一名29岁的患者,该患者在成年早期被诊断为着色性干皮病变异型或色素沉着性类干皮病,因为对阳光敏感导致皮肤出现退行性变化并发生皮肤癌。该患者在两年内切除了11个皮肤肿瘤,其中4个被证实为鳞状细胞癌,1个为基底细胞癌,6个为癌前病变。然后,该患者接受了异维A酸治疗,剂量为每天每公斤体重2毫克,持续两年。在使用异维A酸治疗的两年中,又切除了3个肿瘤,组织学结果为基底细胞癌和鲍温病。该患者对这种低剂量的维甲酸治疗耐受性良好。世界文献中仅描述了约50例此类患者。